The genetic landscape of high-risk neuroblastomaTrevor J. Pugh, Daniela S. Gerhard, Olena Morozova et al.|Nature Genetics|2013Cited by 1.2k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative TumorsJack F. Shern, Javed Khan, Li Chen et al.|Cancer Discovery|2014Cited by 789
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer ResearchWendy Chang, Javed Khan, Andrew S. Brohl et al.|Clinical Cancer Research|2016Cited by 123
Germline CARD11 Mutation in a Patient with Severe Congenital B Cell LymphocytosisAndrew S. Brohl, Andrew L. Snow, Jeffrey R. Stinson et al.|Journal of Clinical Immunology|2014Cited by 85
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastomaJinesh Gheeya, Javed Khan, Qingrong Chen et al.|Cancer Biology & Therapy|2009Cited by 27